Atlas Trials

Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia

Clinical trial NCT00511069 · COMPLETED

Trial details

NCT number
NCT00511069
Sponsor
University of Bologna
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2006-07-01
Primary completion
2008-02-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.